Израел - Хебрејски - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg; atorvastatin as calcium 40 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

Израел - Хебрејски - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg; atorvastatin as calcium 80 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

Израел - Хебрејски - Ministry of Health

teva pharmaceutical indust.ltd - amlodipine as besylate 10 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina (prinzmetal's or variant angina ). chronic stable angina.

Израел - Хебрејски - Ministry of Health

mediline ltd. - amlodipine as besylate 5 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

Израел - Хебрејски - Ministry of Health

mediline ltd. - amlodipine as besylate 10 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.

Израел - Хебрејски - Ministry of Health

abic ltd. - diltiazem hydrochloride - טבליות בשחרור איטי - diltiazem hydrochloride 120 mg - diltiazem - diltiazem - hypertension: either as monotherapy or with other antihypertensive medications such as diuretics. angina pectoris: chronic stable angina, angina due to coronary artery spasm.

Израел - Хебрејски - Ministry of Health

abic ltd. - atenolol - טבליה - atenolol 100 mg - atenolol

Израел - Хебрејски - Ministry of Health

teva israel ltd - atenolol - טבליה - atenolol 25 mg

Израел - Хебрејски - Ministry of Health

abic ltd. - atenolol - טבליה - atenolol 50 mg - atenolol

Израел - Хебрејски - Ministry of Health

unipharm ltd, israel - metoprolol tartrate - טבליה - metoprolol tartrate 100 mg - metoprolol